Outcomes of Mechanical Thrombectomy for Patients With Stroke Presenting With Low Alberta Stroke Program Early Computed Tomography Score in Early and Late Time Windows.


Journal

Neurosurgery
ISSN: 1524-4040
Titre abrégé: Neurosurgery
Pays: United States
ID NLM: 7802914

Informations de publication

Date de publication:
17 May 2024
Historique:
received: 25 10 2023
accepted: 14 02 2024
medline: 17 5 2024
pubmed: 17 5 2024
entrez: 17 5 2024
Statut: aheadofprint

Résumé

This study aimed to compare outcomes of low Alberta Stroke Program Early Computed Tomography Score (ASPECTS) patients with stroke who underwent mechanical thrombectomy (MT) within 6 hours or 6 to 24 hours after stroke onset. A retrospective cohort study was conducted using data from a large multicenter international registry from 2013 to 2023. Patients with low ASPECTS (2-5) who underwent MT for anterior circulation intracranial large vessel occlusion were included. A propensity matching analysis was conducted for patients presented in the early (<6 hours) vs late (6-24 hours) time window after symptom onset or last known normal. Among the 10 229 patients who underwent MT, 274 met the inclusion criteria. 122 (44.5%) patients were treated in the late window. Early window patients were older (median age, 74 years [IQR, 63-80] vs 66.5 years [IQR, 54-77]; P < .001), had lower proportion of female patients (40.1% vs 54.1%; P = .029), higher median admission National Institutes of Health Stroke Scale score (20 [IQR, 16-24] vs 19 [IQR, 14-22]; P = .004), and a higher prevalence of atrial fibrillation (46.1% vs 27.3; P = .002). Propensity matching yielded a well-matched cohort of 84 patients in each group. Comparing the matched cohorts showed there was no significant difference in acceptable outcomes at 90 days between the 2 groups (odds ratio = 0.90 [95% CI = 0.47-1.71]; P = .70). However, the rate of symptomatic ICH was significantly higher in the early window group compared with the late window group (odds ratio = 2.44 [95% CI = 1.06-6.02]; P = .04). Among patients with anterior circulation large vessel occlusion and low ASPECTS, MT seems to provide a similar benefit to functional outcome for patients presenting <6 hours or 6 to 24 hours after onset.

Sections du résumé

BACKGROUND AND OBJECTIVES OBJECTIVE
This study aimed to compare outcomes of low Alberta Stroke Program Early Computed Tomography Score (ASPECTS) patients with stroke who underwent mechanical thrombectomy (MT) within 6 hours or 6 to 24 hours after stroke onset.
METHODS METHODS
A retrospective cohort study was conducted using data from a large multicenter international registry from 2013 to 2023. Patients with low ASPECTS (2-5) who underwent MT for anterior circulation intracranial large vessel occlusion were included. A propensity matching analysis was conducted for patients presented in the early (<6 hours) vs late (6-24 hours) time window after symptom onset or last known normal.
RESULTS RESULTS
Among the 10 229 patients who underwent MT, 274 met the inclusion criteria. 122 (44.5%) patients were treated in the late window. Early window patients were older (median age, 74 years [IQR, 63-80] vs 66.5 years [IQR, 54-77]; P < .001), had lower proportion of female patients (40.1% vs 54.1%; P = .029), higher median admission National Institutes of Health Stroke Scale score (20 [IQR, 16-24] vs 19 [IQR, 14-22]; P = .004), and a higher prevalence of atrial fibrillation (46.1% vs 27.3; P = .002). Propensity matching yielded a well-matched cohort of 84 patients in each group. Comparing the matched cohorts showed there was no significant difference in acceptable outcomes at 90 days between the 2 groups (odds ratio = 0.90 [95% CI = 0.47-1.71]; P = .70). However, the rate of symptomatic ICH was significantly higher in the early window group compared with the late window group (odds ratio = 2.44 [95% CI = 1.06-6.02]; P = .04).
CONCLUSION CONCLUSIONS
Among patients with anterior circulation large vessel occlusion and low ASPECTS, MT seems to provide a similar benefit to functional outcome for patients presenting <6 hours or 6 to 24 hours after onset.

Identifiants

pubmed: 38758725
doi: 10.1227/neu.0000000000002992
pii: 00006123-990000000-01169
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Stryker

Informations de copyright

Copyright © Congress of Neurological Surgeons 2024. All rights reserved.

Références

Powers WJ, Derdeyn CP, Biller J, et al. 2015 American Heart Association/American Stroke Association focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46(10):3020-3035.
Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019;50(12):e344-e418.
Jadhav AP, Desai SM, Jovin TG. Indications for mechanical thrombectomy for acute ischemic stroke: current guidelines and beyond. Neurology. 2021;97(20 Suppl 2):S126-S136.
Goyal M, Menon BK, van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387(10029):1723-1731.
Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018;378(1):11-21.
Albers GW, Marks MP, Kemp S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med. 2018;378(8):708-718.
Yoshimura S, Sakai N, Yamagami H, et al. Endovascular therapy for acute stroke with a large ischemic region. N Engl J Med. 2022;386(14):1303-1313.
Sarraj A, Hassan AE, Abraham MG, et al. Trial of endovascular thrombectomy for large ischemic strokes. N Engl J Med. 2023;388(14):1259-1271.
Huo X, Ma G, Tong X, et al. Trial of endovascular therapy for acute ischemic stroke with large infarct. N Engl J Med. 2023;388(14):1272-1283.
von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344-349.
Manning NW, Chapot R, Meyers PM. Endovascular stroke management: key elements of success. Cerebrovasc Dis. 2016;42(3-4):170-177.
Badhiwala JH, Nassiri F, Alhazzani W, et al. Endovascular thrombectomy for acute ischemic stroke: a meta-analysis. JAMA. 2015;314(17):1832-1843.
Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274(13):1017-1025.
Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083-3107.
Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46(3):399-424.
Zaidat OO, Kasab SA, Sheth S, et al. TESLA trial: rationale, protocol, and design. Stroke Vasc Interv Neurol. 2023;3(4):e000787.
Yoo AJ, Berkhemer OA, Fransen PSS, et al. Effect of baseline Alberta Stroke Program Early CT Score on safety and efficacy of intra-arterial treatment: a subgroup analysis of a randomised phase 3 trial (MR CLEAN). Lancet Neurol. 2016;15(7):685-694.
Desai SM, Aghaebrahim A, Siegler JE, et al. Duration of ischemia impacts postreperfusion clinical outcomes independent of follow-up infarct volume. Stroke Vasc Interv Neurol. 2022;2(5):e000153.
Wang DT, Churilov L, Dowling R, Mitchell P, Yan B. Successful recanalization post endovascular therapy is associated with a decreased risk of intracranial haemorrhage: a retrospective study. BMC Neurol. 2015;15:185.
Bang OY, Saver JL, Kim SJ, et al. Collateral flow averts hemorrhagic transformation after endovascular therapy for acute ischemic stroke. Stroke. 2011;42(8):2235-2239.
Tan BY, Wan-Yee K, Paliwal P, et al. Good intracranial collaterals trump poor ASPECTS (Alberta stroke program early CT score) for intravenous thrombolysis in anterior circulation acute ischemic stroke. Stroke. 2016;47(9):2292-2298.
Tong X, Burgin WS, Ren Z, et al. Association of stroke subtype with hemorrhagic transformation mediated by thrombectomy pass: data from the ANGEL-ACT registry. Stroke. 2022;53(6):1984-1992.

Auteurs

Sameh Samir Elawady (SS)

Department of Neurosurgery, Division of Neuroendovascular Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.

Conor Cunningham (C)

Department of Neurosurgery, Division of Neuroendovascular Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.

Hidetoshi Matsukawa (H)

Department of Neurosurgery, Division of Neuroendovascular Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
Department of Neurosurgery, Hyogo Medical University, Nishinomiya, Japan.

Kazutaka Uchida (K)

Department of Neurosurgery, Division of Neuroendovascular Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
Department of Neurosurgery, Hyogo Medical University, Nishinomiya, Japan.

Steven Lin (S)

Department of Neurosurgery, Division of Neuroendovascular Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.

Ilko Maier (I)

Department of Neurology, University Medical Center Göttingen, Göttingen, Germany.

Pascal Jabbour (P)

Department of Neurosurgery, Thomas Jefferson University Hospitals, Philadelphia, Pennsylvania, USA.

Joon-Tae Kim (JT)

Department of Neurology, Chonnam National University Medical School, Chonnam National University Hospital, Gwangju, Korea.

Stacey Quintero Wolfe (SQ)

Department of Neurosurgery, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.

Ansaar Rai (A)

Department of Radiology, West Virginia School of Medicine, Morgantown, West Virginia, USA.

Robert M Starke (RM)

Department of Neurosurgery, University of Miami Health System, Miami, Florida, USA.

Marios-Nikos Psychogios (MN)

Department of Interventional and Diagnostical Neuroradiology, University of Basel, Basel, Switzerland.

Edgar A Samaniego (EA)

Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.

Adam Arthur (A)

Department of Neurosurgery, Semmes-Murphey Neurologic and Spine Clinic, University of Tennessee Health Science Center, Memphis, Tennessee, USA.

Shinichi Yoshimura (S)

Department of Neurosurgery, Hyogo Medical University, Nishinomiya, Japan.

Hugo Cuellar (H)

Department of Neurosurgery and Neurointerventional Radiology, Louisiana State University, Shreveport, Louisiana, USA.

Jonathan A Grossberg (JA)

Neurosurgery, Radiology and Imaging Sciences, Emory University, Atlanta, Georgia, USA.

Ali Alawieh (A)

Neurosurgery, Radiology and Imaging Sciences, Emory University, Atlanta, Georgia, USA.

Daniele G Romano (DG)

Department of Neuroradiology, University Hospital San Giovanni di Dio e Ruggi d'Aragona, University of Salerno, Salerno, Italy.

Omar Tanweer (O)

Department of Neurosurgery, Baylor College of Medicine, Houston, Texas, USA.

Justin Mascitelli (J)

Department of Neurosurgery, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.

Isabel Fragata (I)

Department of Neuroradiology, Hospital São José Centro Hospitalar, Lisboa, Portugal.

Adam Polifka (A)

Department of Neurosurgery, University of Florida, Gainesville, Florida, USA.

Joshua Osbun (J)

Department of Neurological Surgery, Washington University, St Louis, Missouri, USA.

Roberto Crosa (R)

Department of Neurosurgery, Endovascular Neurological Center, Montevideo, Uruguay.

Charles Matouk (C)

Department of Neurosurgery, Yale School of Medicine, New Haven, Connecticut, USA.

Min S Park (MS)

Department of Neurosurgery, University of Virginia, Charlottesville, Virginia, USA.

Michael R Levitt (MR)

Department of Neurosurgery, University of Washington, Seattle, Washington, USA.

Waleed Brinjikji (W)

Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota, USA.

Mark Moss (M)

Department of Neuroradiology, Washington Regional J.B. Hunt Transport Services Neuroscience Institute, Fayetteville, Arizona, USA.

Travis Dumont (T)

Department of Neurosurgery, University of Arizona, Tucson, Arizona, USA.

Richard Williamson (R)

Department of Neurosurgery, Allegheny Health Network, Pittsburgh, Pennsylvania, USA.

Pedro Navia (P)

Department of Neuroradiology, Hospital Universitario La Paz, Madrid, Spain.

Peter Kan (P)

Department of Neurological Surgery, University of Texas Medical Branch, Galveston, Texas, USA.

Reade De Leacy (R)

Department of Neurosurgery, Mount Sinai Health System, New York, New York, USA.

Shakeel Chowdhry (S)

Department of Neurosurgery, NorthShore University Health System, Evanston, Illinois, USA.

Mohamad Ezzeldin (M)

Department of Clinical Neuroscience, University of Houston, HCA Houston Healthcare Kingwood, Houston, Texas, USA.

Alejandro M Spiotta (AM)

Department of Neurosurgery, Division of Neuroendovascular Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.

Sami Al Kasab (S)

Department of Neurosurgery, Division of Neuroendovascular Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.

Classifications MeSH